TUMORGPLAT Making patient-derived tumor organoids a reliable cancer therapy testing platform
- Coordinator
- Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €245k
- Total cost
- —
- Partners
- 6 organisations in 3 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101236487
What the project is doing
In the project's own words, from its summary on CORDIS.
We aim to establish a European network of experts in non-animal preclinical models to develop the next generation of patient-derived tumor organoids (PDTOs) for both solid and hematological cancers. To this end, we have selected non-small cell lung cancer as a model, given its high incidence, and chronic lymphocytic leukemia and follicular lymphoma as representative B cell malignancies. These PDTOs will incorporate a novel, tissue-specific artificial extracellular matrix, created using tailored 3D biohybrid hydrogels designed to mimic the human tumor microenvironment (TME).
By integrating patient-derived tumor, immune, and stromal cells, the PDTOs will closely replicate the complexity of the original tumors, which will be evaluated using a multi-technique approach, including comprehensive omics characterization. Our ultimate goal is to establish a robust platform for testing innovative therapies—particularly radiotherapy and immunotherapy—within the framework of personalized medicine. Specifically, we will focus on adoptive cell therapies using CAR T and NK cells, neutron capture (radio)therapy, and their combination.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Coordinator |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Participant |
| Universitat Politecnica De Valencia | Valencia | Spain | Participant |
| Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | Italy | Participant |
| Universita Degli Studi Di Pavia | Pavia | Italy | Participant |
| Immundnz Limited | Sittingbourne | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI